Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marie Saint-Remy

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Cellular Immunology|October 6, 2015
T cell response to FVIIIMarc Jacquemin, Jean-Marie Saint-Remy
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Models for assessing immunogenicity and efficacy of new therapeutics for the treatment of haemophiliaJean-Marie Saint-Remy, Birgit M Reipert, Dougald M Monroe
Thrombosis Research|February 5, 2003
Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factorAde Kallas, Margus Pooga, Abdellah Benhida, et al.
Frontiers in Immunology|July 24, 2018
Corrigendum: Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse ModelElin Malek Abrahimians, Luc Vander Elst, Vincent A Carlier, et al.
Frontiers in Immunology|March 15, 2016
Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse ModelElin Malek Abrahimians, Luc Vander Elst, Vincent A Carlier, et al.
Blood|March 31, 2010
Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage poolTina Shahani, Renaud Lavend'homme, Aernout Luttun, et al.
Human Gene Therapy|December 30, 2015
Suppression of Immune Response to Adenovirus Serotype 5 Vector by Immunization with Peptides Containing an MHC Class II Epitope and a Thio-Oxidoreductase MotifWei Miao, Roxana Roohi Ahangarani, Vincent Carlier, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2006
Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergenSonia de Halleux, Enrico Stura, Luc VanderElst, et al.
The Journal of Biological Chemistry|May 16, 2002
Low molecular weight peptides restore the procoagulant activity of factor VIII in the presence of the potent inhibitor antibody ESH8Sylvie Villard, Dominique Piquer, Sanjee Raut, et al.
Blood|April 20, 2002
Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis modelInderjit Singh, Alberto Smith, Beatrijs Vanzieleghem, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Cellular Immunology|October 6, 2015
T cell response to FVIIIMarc Jacquemin, Jean-Marie Saint-Remy
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Models for assessing immunogenicity and efficacy of new therapeutics for the treatment of haemophiliaJean-Marie Saint-Remy, Birgit M Reipert, Dougald M Monroe
Thrombosis Research|February 5, 2003
Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factorAde Kallas, Margus Pooga, Abdellah Benhida, et al.
Frontiers in Immunology|July 24, 2018
Corrigendum: Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse ModelElin Malek Abrahimians, Luc Vander Elst, Vincent A Carlier, et al.
Frontiers in Immunology|March 15, 2016
Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse ModelElin Malek Abrahimians, Luc Vander Elst, Vincent A Carlier, et al.
Blood|March 31, 2010
Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage poolTina Shahani, Renaud Lavend'homme, Aernout Luttun, et al.
Human Gene Therapy|December 30, 2015
Suppression of Immune Response to Adenovirus Serotype 5 Vector by Immunization with Peptides Containing an MHC Class II Epitope and a Thio-Oxidoreductase MotifWei Miao, Roxana Roohi Ahangarani, Vincent Carlier, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2006
Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergenSonia de Halleux, Enrico Stura, Luc VanderElst, et al.
The Journal of Biological Chemistry|May 16, 2002
Low molecular weight peptides restore the procoagulant activity of factor VIII in the presence of the potent inhibitor antibody ESH8Sylvie Villard, Dominique Piquer, Sanjee Raut, et al.
Blood|April 20, 2002
Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis modelInderjit Singh, Alberto Smith, Beatrijs Vanzieleghem, et al.
Pageof 3